{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:38:10Z","timestamp":1783647490622,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06418-9","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T01:19:50Z","timestamp":1756257590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erythropoietic protoporphyria in childhood: clinical clues, missed diagnoses and emerging therapy"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8340-1196","authenticated-orcid":false,"given":"Moritz","family":"Toenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-6403","authenticated-orcid":false,"given":"Tim","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"6418_CR1","doi-asserted-by":"crossref","unstructured":"Minder A, Kluijver LG, Barman-Aks\u00f6zen J, Minder EI, Langendonk JG (2025) Erythropoietic protoporphyrias: pathogenesis, diagnosis and management. Liver Int [Internet] [cited 2025 June 15];45:e16027. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11669082\/","DOI":"10.1111\/liv.16027"},{"key":"6418_CR2","doi-asserted-by":"crossref","unstructured":"Dickey AK, Naik H, Keel SB, Levy C, Beaven SW, Elmariah SB et al (2023) Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria. J Am Acad Dermatol [Internet]. [cited 2025 May 23];89:1227\u201337. Available from: https:\/\/www.jaad.org\/article\/S0190-9622(22)02611-1\/abstract","DOI":"10.1016\/j.jaad.2022.08.036"},{"key":"6418_CR3","unstructured":"CLINUVEL Pharmaceuticals Ltd. (2025) Preliminary results from SCENESSE\u00ae adolescent EPP study: consistent safety profile in adolescents [Internet]. Report No.: CUV052. CLINUVEL Pharmaceuticals Ltd., Melbourne. Available from: https:\/\/epp-deutschland.de\/wp-content\/uploads\/2025\/02\/20250210-preliminary-results-from-scenesse-adolescent-epp-study.pdf. Accessed 15 Mar 2025"},{"key":"6418_CR4","doi-asserted-by":"publisher","unstructured":"Kluijver LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, Witters P, Rymen D et al (2024)\u00a0 Quality of life in children with erythropoietic protoporphyria: a case\u2013control study. The Journal of Dermatology [Internet]. [cited 2025 June 16];51:1068\u201378. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1111\/1346-8138.17348","DOI":"10.1111\/1346-8138.17348"},{"key":"6418_CR5","unstructured":"Bonkovsky HL, Rudnick SR (2025) Erythropoietic Protoporphyria and X-linked Protoporphyria - Endocrine and Metabolic Disorders [Internet]. MSD Manual Professional Edition. [cited 2025 Apr 22]. Available from: https:\/\/www.msdmanuals.com\/professional\/endocrine-and-metabolic-disorders\/the-porphyrias\/erythropoietic-protoporphyria-and-x-linked-protoporphyria"},{"key":"6418_CR6","doi-asserted-by":"crossref","unstructured":"Heerfordt IM, Philipsen PA, Lerche CM, Wulf HC (2023) Protection against visible light by dihydroxyacetone in erythropoietic protoporphyria. Photodiagnosis and Photodynamic Therapy [Internet].\u00a0 [cited 2025 June 15];41. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1572100023000315","DOI":"10.1016\/j.pdpdt.2023.103302"},{"key":"6418_CR7","doi-asserted-by":"publisher","unstructured":"Tumminelli C, Burlo F, Pastore S, Severini GM, Berti I, Marchini S et al (2023) Erythropoietic protoporphyria: case reports for clinical and therapeutic hints. Italian Journal of Pediatrics [Internet]. [cited 2025 Apr 22];49:1\u20137. Available from: https:\/\/doi.org\/10.1186\/s13052-023-01544-2","DOI":"10.1186\/s13052-023-01544-2"},{"key":"6418_CR8","doi-asserted-by":"publisher","unstructured":"Langendonk JG, Balwani M, Anderson KE, Bonkovsky HL, Anstey AV, Bissell DM et al (2015)\u00a0 Afamelanotide for erythropoietic protoporphyria. New England Journal of Medicine [Internet].\u00a0 [cited 2025 Apr 22];373:48\u201359. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa1411481","DOI":"10.1056\/NEJMoa1411481"},{"key":"6418_CR9","doi-asserted-by":"publisher","unstructured":"Biolcati G, Hanneken S, Minder EI, Neumann NJ, Wilson JHP, Wolgen PJ et al (2021) Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL. J Patient Rep Outcomes [Internet]. [cited 2025 May 23];5:65. Available from: https:\/\/jpro.springeropen.com\/articles\/https:\/\/doi.org\/10.1186\/s41687-021-00345-7","DOI":"10.1186\/s41687-021-00345-7"},{"key":"6418_CR10","unstructured":"Drug Trials Snapshots: SCENESSE [Internet]. Drug trials snapshots: SCENESSE. FDA; 2019 [cited 2025 June 15]. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshots-scenesse"},{"key":"6418_CR11","unstructured":"National Institute for Health and Care Excellence (NICE). Afamelanotide for treating erythropoietic protoporphyria [Internet]. NICE; 2023 [cited 2025 June 12]. Available from: https:\/\/www.nice.org.uk\/guidance\/hst27"},{"key":"6418_CR12","unstructured":"Faye F, Castro R, Dubief J (2025)\u00a0 The impact of living with a rare disease: barriers and enablers of independent living and social participation. A Rare Barometer survey. [cited 2025 June 16]; Available from: https:\/\/www.eurordis.org\/publications\/rb-dailylife-report\/"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06418-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06418-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T15:10:37Z","timestamp":1774624237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06418-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["6418"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06418-9","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of the anonymised patient quote was obtained from the child\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"580"}}